Previous studies have established a correlation between the intratumoral heterogeneity of CD8 T cell distribution and response to ICB in immunologically “hot” tumors, with a heterogeneous distribution of PET signal within the tumor considered an indicator of poor outcomes [18]. The gene discussed is CD8A; the disease is neoplasm.